Medtronic Launches Percept™ RC, the World’s First Rechargeable, Sensing-Enabled Closed-Loop Deep Brain Stimulation System, in Clinical Use Across China

Nov 20, 2025 18:58 CST Updated 18:58

Medtronic

Medical Device Manufacturer

November 2025,World's First Rechargeable, Sensing Closed-Loop Brain Stimulator Percept™ RCOfficially launched clinical application in major hospitals in Beijing, Anhui, Shanxi and other provinces and cities.

The team led by Director Zhang Jianguo from Beijing Tiantan Hospital, Capital Medical University; the team led by Director Mao Zhiqi from Beijing Shijitan Hospital, Capital Medical University; the team led by Directors Ling Zhipeng and Li Jun, including Director Ji Wei's team from Hefei Huaan Brain Hospital; the neurosurgery team from Beijing Gaobo Hospital; and the team led by Directors Ji Hongming and Ma Jiuhong from Shanxi Provincial People's Hospital.Successful Implementation of China's First Batch of Rechargeable, Sensing Closed-Loop Brain Pacemaker Percept™ RC Implants.

Next, the product will be put into clinical application in major hospitals in Shanghai, Guangdong, Shandong and other provinces and cities.

The rechargeable, perceptual closed-loop brain stimulator Percept™ RC, developed by the global medical technology company Medtronic, integrates artificial intelligence and brain-computer interface technology.The world's first brain pacemaker system approved by China's NMPA, the U.S. FDA, and the EU CE, featuring rechargeability, sensing capability, directional stimulation, and compatibility with both 3.0T and 1.5T full-body MRI scans., used forTreatmentParkinson's disease, essential tremor, dystonia, and drug-resistant epilepsyAnd other complex neurological disorders.The product has recently been"2025 Invention of the Year" by TIME Magazine, and as a "star exhibit" consecutively appeared at the 2024 and 2025 China International Import Expo, receiving extensive media coverage and patient attention.

From the CIIE stage to patients, the clinical application of Percept™ RC marks a major breakthrough in brain pacemaker treatment.This has advanced the application of brain-computer interface technology in China for treating neurological disorders such as Parkinson's disease, ushering in a new era of neuromodulation and brain-computer interface technology to improve human health, and offering Chinese patients smarter, more precise, long-term, and comfortable treatment options.

Rechargeable, Sensing Closed-Loop Brain Stimulator Percept™ RC

Displayed at the 8th CIIE

Deep Brain Stimulation (DBS), commonly known as the "brain pacemaker," involves electrodes implanted in the brain that emit electrical pulses to stimulate specific nuclei deep within the brain, thereby alleviating patients' symptoms. It is currently the internationally recognized preferred surgical treatment for Parkinson's disease. In 1987, Medtronic, in collaboration with Professor Benabid, a French neurosurgeon, successfully performed the world’s first DBS surgery. This therapy officially entered China in 1999 and, to date, has been clinically applied globally for over 35 years.

Schematic Diagram of the Working Principle of the Rechargeable, Sensing Closed-Loop Brain Stimulator Percept™ RC

Compared with traditional brain pacemakers that can only provide one-way treatment, the rechargeable and perceptible closed-loop brain pacemaker Percept™ RC integrates artificial intelligence and brain-computer interface technology to sense and analyze patients' brain electrical activities in real time, allowing treatment to be more aligned with patients’ condition changes and needs, achieving personalized precision treatment.

Moreover, the all-around technological breakthroughs of Percept™ RC have also brought patients a higher quality treatment experience:The world's smallest and thinnest brain pacemaker,37% smaller than traditional brain pacemakers, providing patients with a more comfortable implant experience; extended lifespan, utilizing Medtronic's Overdrive™ patented battery technology and special lithium titanate battery materials to ensure long-term, safe, and stable treatment for patients; unconditionally approved for full-body 3.0T & 1.5T MRI compatibility without time restrictions on scanning, safeguarding patients' future rights and safety when undergoing MRI examinations; combined with the SenSight™ directional lead, unlocking more flexible and diverse programming functions to achieve "maximized efficacy and minimized side effects."

As a witness, participant, and contributor to the rapid development of China's healthcare industry, Medtronic has always been "In China, For China," continuously and acceleratingly introducing innovative cutting-edge technologies. We look forward to the arrival of this revolutionary product empowering the clinical diagnosis and treatment of nervous system diseases and the research on disease mechanisms, alleviating the suffering, restoring the health, and extending the life of the vast number of patients tormented by Parkinson's disease and other ailments.

# Siyu MedTech Recommended Articles Collection

Recent Articles

The Era of Chinese-Made Medical Devices Has Arrived!

A "Doctor-Savvy" Robotic Arm Unveils a New Era for Orthopedic Robots

In China, how does a company specializing in ophthalmology keep pace with time? | Exclusive Interview with Alcon

From Fragmentation to Symbiosis: Viewing Medtronic's Systems Thinking at the CIIE

19 Companies Overview | Medical Device Exhibition at the 2025 CIIE

Another Medical Company Successfully IPOs, Reflecting the Industry's Booms and Busts

Global Medical Device Watch

▌Capital Radar｜Money Flow

Overseas Financing Events |Financing Events in China |Overseas Acquisition Cases |Domestic Acquisition Cases

Foreign Enterprise IPO |Chinese Companies' IPO |Foreign Enterprise Earnings Reports |Earnings Reports of Domestic Enterprises

▌New Product Approved｜Clearance Tracker

Approved by NMPA | FDA | CE

▌Latest Exhibition | Expo Watch

Exhibition Preview/Review/Roundup

▌Instrument BD BD

SIYU Annual Event Review:The First Global Ophthalmology Conference | The First Global Orthopedics Conference | The First Global Cardiovascular Conference| The First Global Medical Aesthetics Technology Conference |The 2nd Global Medical Technology Conference|The 3rd Global Surgical Robotics Conference

Content Declaration:"SiYu MedTech" tracks global medical technology advancements, aiming to deliver technical and industry knowledge. All content is for industry exchange and academic discussion only, not constituting medical advice or commercial promotion. Information about companies, products, and registrations mentioned in the text is sourced from publicly available materials or verified channels. If there are any errors or omissions, please contact us for corrections. Email: jacky@suribot.com

Copyright Statement:The original article of "SiYu MedTech" is copyrighted by Beijing SiYu BoTe Technology Co., Ltd. Without authorization, it shall not be reprinted, excerpted, or mirrored to other websites, official accounts, or commercial platforms; for reprinting, please contact the backstage to obtain authorization. For any unauthorized full-text reprinting, content rewriting, or adaptation, this platform reserves the right to pursue legal responsibilities.